167 related articles for article (PubMed ID: 27206843)
1. A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.
Rogers JT; Venkataramani V; Washburn C; Liu Y; Tummala V; Jiang H; Smith A; Cahill CM
J Neurochem; 2016 Aug; 138(3):479-94. PubMed ID: 27206843
[TBL] [Abstract][Full Text] [Related]
2. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
3. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
Bandyopadhyay S; Cahill C; Balleidier A; Huang C; Lahiri DK; Huang X; Rogers JT
PLoS One; 2013; 8(7):e65978. PubMed ID: 23935819
[TBL] [Abstract][Full Text] [Related]
4. Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.
Bandyopadhyay S; Huang X; Cho H; Greig NH; Youdim MB; Rogers JT
J Neural Transm Suppl; 2006; (71):237-47. PubMed ID: 17447434
[TBL] [Abstract][Full Text] [Related]
5. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
Rogers JT; Randall JD; Cahill CM; Eder PS; Huang X; Gunshin H; Leiter L; McPhee J; Sarang SS; Utsuki T; Greig NH; Lahiri DK; Tanzi RE; Bush AI; Giordano T; Gullans SR
J Biol Chem; 2002 Nov; 277(47):45518-28. PubMed ID: 12198135
[TBL] [Abstract][Full Text] [Related]
6. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.
Cho HH; Cahill CM; Vanderburg CR; Scherzer CR; Wang B; Huang X; Rogers JT
J Biol Chem; 2010 Oct; 285(41):31217-32. PubMed ID: 20558735
[TBL] [Abstract][Full Text] [Related]
7. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
Rogers JT; Bush AI; Cho HH; Smith DH; Thomson AM; Friedlich AL; Lahiri DK; Leedman PJ; Huang X; Cahill CM
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1282-7. PubMed ID: 19021541
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
Bandyopadhyay S; Rogers JT
Biochem Pharmacol; 2014 Apr; 88(4):486-94. PubMed ID: 24513321
[TBL] [Abstract][Full Text] [Related]
9. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
10. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
11. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
12. Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.
Avramovich-Tirosh Y; Amit T; Bar-Am O; Weinreb O; Youdim MB
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S2. PubMed ID: 19090990
[TBL] [Abstract][Full Text] [Related]
13. The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines.
Hicks DA; Makova NZ; Gough M; Parkin ET; Nalivaeva NN; Turner AJ
J Biol Chem; 2013 Sep; 288(36):26039-26051. PubMed ID: 23897820
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells.
Matsumoto K; Akao Y; Yi H; Shamoto-Nagai M; Maruyama W; Naoi M
J Neural Transm (Vienna); 2006 Feb; 113(2):125-35. PubMed ID: 15959846
[TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.
Cahill CM; Lahiri DK; Huang X; Rogers JT
Biochim Biophys Acta; 2009 Jul; 1790(7):615-28. PubMed ID: 19166904
[TBL] [Abstract][Full Text] [Related]
16. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
Morse LJ; Payton SM; Cuny GD; Rogers JT
J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
[TBL] [Abstract][Full Text] [Related]
17. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
18. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
19. The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models.
Amit T; Bar-Am O; Mechlovich D; Kupershmidt L; Youdim MBH; Weinreb O
Neuropharmacology; 2017 Sep; 123():359-367. PubMed ID: 28571715
[TBL] [Abstract][Full Text] [Related]
20. The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons.
Ji C; Steimle BL; Bailey DK; Kosman DJ
Cell Mol Neurobiol; 2018 May; 38(4):941-954. PubMed ID: 29177638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
